AMERICAN CENTURY COMPANIES INC

Holdings History for Celldex Therapeutics, Inc. - Common Stock, par value $0.001 per share (CLDX)

Symbol: CLDX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$23,227,976	855,226	+39,666	+4.9%	$27.16	Q4 2025
30 Sep 2025	0.01%	+0%	$21,098,594	815,560	+35,575	+4.6%	$25.87	Q3 2025
30 Jun 2025	0.01%	+0%	$15,872,738	779,985	+154,664	+25%	$20.35	Q2 2025
31 Mar 2025	0.01%	+0%	$11,349,609	625,321	+16,864		$18.15	Q1 2025
31 Dec 2024	0.01%	+0%	$15,375,741	608,457	+193,093	+46%	$25.27	Q4 2024
30 Sep 2024	0.01%	-0%	$14,118,267	415,364	-636	-0.15%	$33.99	Q3 2024
30 Jun 2024	0.01%	+0.01%	$15,396,196	416,000	+233,928	+128%	$37.01	Q2 2024
31 Mar 2024	0%	+0%	$7,641,566	182,072	+21,021	+13%	$41.97	Q1 2024
31 Dec 2023	0%	+0%	$6,387,308	161,051	+191	+0.12%	$39.66	Q4 2023
30 Sep 2023	0%	0%	$4,426,865	160,860	+23	+0.01%	$27.52	Q3 2023
30 Jun 2023	0%	-0%	$5,457,214	160,837	-4,891	-3%	$33.93	Q2 2023
31 Mar 2023	0%	-0%	$5,947,042	165,728	-32,233	-16%	$35.88	Q1 2023
31 Dec 2022	0.01%	+0%	$8,823,121	197,961	+2,399	+1.2%	$44.57	Q4 2022
30 Sep 2022	0%	-0%	$5,497,000	195,562	-723	-0.37%	$28.11	Q3 2022
30 Jun 2022	0%	+0%	$5,292,000	196,285	+13,268	+7.2%	$26.96	Q2 2022
31 Mar 2022	0%	-0%	$6,234,000	183,017	-1,414	-0.77%	$34.06	Q1 2022
31 Dec 2021	0%	+0%	$7,126,000	184,431	+184,431	NEW	$38.64	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.